Anke zur Muehlen

CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany.

Part of Infinity Pharmaceuticals, Inc., Biofrontera Pharma GmbH is a German company that provides natural products drug discovery services. The company is based in Leverkusen, Germany. The CEOs are María del Pilar de la Huerta Martínez, Montserrat Foguet. The private company was founded in 2003. Biofrontera Pharma was acquired by Discovery Partners International, Inc. from Biofrontera AG on June 30, 2005.

QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany.

Delphi Unternehmensberatung AG provides investment services. The private company is based in Heidelberg, Germany.

Creathor Venture Management GmbH is an independent private equity firm specialized in technology venture capital investing. Creathor was foundedi n 2003 and is headquartered in Bad Homburg near Frankfurt in central Germany. The management invests their own capital, and manages venture capital funds on behalf of institutions.

Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany.

Araclon Biotech SL researches and develops therapies and diagnostic methods for Alzheimer’s disease. Its research areas include early diagnosis of Alzheimer’s disease; therapy for Alzheimer’s disease; development of a predictive test for the Alzheimer’s disease in asymptomatic individuals; and development of therapy for Parkinson’s disease. The company was founded on January 27, 2004 and is headquartered in Zaragoza, Spain.

Part of Wilh. Werhahn KG, HUMAN Gesellschaft für Biochemica und Diagnostica mbH is a healthcare company based in Wiesbaden, Germany. HUMAN has been serving the healthcare sector for 50 years with high-quality products, renowned services, and individualized support. With R&D and production anchored in and with partners in more than 160 countries, HUMAN is regarded as a player in the IVD industry. The German company's worldwide network of subsidiaries and distributors guarantees being close to the users, providing service and support. HUMAN offers a constant supply of products and support, and its customers' satisfaction is its success. The private company was founded in 1972. Ralph Neuberger has been the CEO of the company since 2002.

Fortuna Maschinenbau Holding AG engages in the development, construction, production, renting out, leasing, and distribution of bakery and food processing equipment. It also provides maintenance services for such machines as well as consulting services. The company was founded on December 7, 2006 and is headquartered in Bad Staffelstein, Germany.

SPARTA Invest AG engages in the acquisition, management, and disposal of participating interests in corporations and partnerships as well as listed stock corporations. Its business activities also include the management of its own assets, financial transactions, and transactions in financial instruments. The company was founded on May 25, 2004 and is headquartered in Heidelberg, Germany.

Cryotherapeutics SA develops and markets a cryotherapy system, with focus on highlighting the safety and efficacy of cryoneergy in the cardiovascular system. The firm specializes in the design of a proprietary system to be used in the treatment of coronary artery diseases that cause heart attacks. Its focus areas encompass technology research, system development, and early-stage product commercialization. The company was founded by Randell L. Werneth, John Yianni and Maurice Buchbinder on September 8, 2009 and is headquartered in Cologne, Germany.

ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland.

STRAWTEC Group AG provides engineering and construction services. The firm offers installation, finishing and housing services. The company is headquartered in Heidelberg, Germany.

AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany.

Chundsell Medicals AB develops and markets novel molecular diagnostics for the treatment of cancer. Its product measures the expression pattern of selected embryonic stem cell genes in prostate cancer core needle biopsies. The company was founded by Sunne Rosell and Chunde Li in 2007 and is headquartered in Solna, Sweden.

Vaxdyn SL discovers and develops antigens. Its products include pipeline, clinical need and R&D programs. The company was founded by Jeronimo Pachon, Pilar Perez-Romero and Michael J. McConnell in 2011 and is headquartered in Seville, Spain.

INDICAL BIOSCIENCE GmbH provides solutions for molecular diagnostics for vet-specific applications. It offers diagnostics for better animal and human health. The company was founded in 1996 and is headquartered in Leipzig, Germany.

Part of AdhexPharma SAS, tesa Labtec GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Langenfeld, Germany. The company was founded in 1990 by Günter Cordes. The CEO is Detlev Radloff. tesa Labtec was acquired by AdhexPharma SAS from maxingvest AG on September 30, 2022.

Antibióticos de León SLU develops, manufactures, sells, and distributes active pharmaceutical ingredients for penicillin-based antibiotics. Its products include sterile antibiotics and oral semisynthesis. The company was founded in 2014 and is headquartered in Leon, Spain.

Deutsche Balaton Biotech AG is an investment holding German company. The private company is based in Heidelberg, Germany.

YVAL Idiosynkratische Investments SE provides investment services. The private company is based in Heidelberg, Germany. The CEO of the German company is Wilhelm Konrad Zours.

NeraCare GmbH operates clinics. The company is based in Cologne, Germany.

Indical Topco AB is a Swedish company that owns and manages shares, as well as real and movable properties. The private company is based in Stockholm, Sweden.

Avelo AG is a Swiss company that aims to save lives by providing fast and actionable infectious disease diagnosis closer to the patient. Avelo is based in Schlieren, CH. The company's solution is a breath collection device that works with existing molecular tests to detect multiple respiratory tract infections causing pneumonia. The company was founded in 2020 by Melanie Aregger and Tobias Broger, with Melanie Aregger serving as the CEO since 2020.

Genetrix SL develops biotechnological solutions. It is comprised of technology and biomedicine companies in order to maximize the value of the Group. The company was founded in May 20, 2003 and is headquartered in Madrid, Spain.